five

Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients With mCRC

收藏
NIAID Data Ecosystem2026-05-01 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2751724
下载链接
链接失效反馈
官方服务:
资源简介:
This study is a phase II study to evaluate the efficacy, safety and tolerability of HLX26 and HLX10 in the treatment of patients with metastatic colorectal carcinoma that had received 3 prior therapies.
创建时间:
2023-06-15
二维码
社区交流群
二维码
科研交流群
商业服务